Aehr Test Systems (AEHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Aehr Systems is downgraded to "hold" after a 292% rally, with shares now near fair value. Recent Q2 results showed YoY revenue decline and weak profitability, but liquidity improved and backlog remains healthy at $11.8–$18.3 million. Management guides for 2H26 revenue of $25–$30 million and near-breakeven EPS, with strong AI and data center semiconductor demand supporting future growth.
Small-cap semiconductor stock Aehr Test Systems NASDAQ: AEHR has gotten off to an absolutely blistering start to 2026. Overall, its return on the year comes in well above 100% as Aehr continues to provide positive updates on its artificial intelligence (AI) business.
Aehr Test Systems (NASDAQ: AEHR - Get Free Report)'s share price traded up 8.1% during mid-day trading on Friday. The company traded as high as $31.32 and last traded at $32.7190. 126,707 shares were traded during trading, a decline of 90% from the average session volume of 1,312,105 shares. The stock had previously closed at
Small-cap semiconductor stock Aehr Test Systems NASDAQ: AEHR just secured a huge win. On Feb. 11, AEHR soared by over 26% as the company made a key announcement.
While the Magnificent Seven and massive technology conglomerates often dominate financial headlines, a quieter but equally significant shift is occurring in the small-cap sector. January 2026 has emerged as a critical month for a few specific companies valued under $2 billion.
For shares of Aehr Test Systems NASDAQ: AEHR, it's hard to imagine a hotter start to 2026. As of the Jan. 20 close, the stock is already up 44% on the year.
Aehr Test Systems reported disappointing Q2/FY2026 results, with sales missing consensus expectations by approximately 15% and gross margins declining to new multi-year lows. While the company continued to burn cash, Aehr used the ongoing AI hype to replenish its dwindling cash balances by selling shares at elevated prices into the open market. On the conference call, management disclosed a slew of operational setbacks and order delays. As a result, H2/FY2026 results are expected to fall well short of consensus expectations.
Aehr Test Systems, Inc. (AEHR) Q2 2026 Earnings Call Transcript
Aehr Test Systems, Inc. (NASDAQ:AEHR ) Q1 2026 Earnings Call October 6, 2025 5:00 PM EDT Company Participants Gayn Erickson - President, CEO & Director Chris Siu - CFO, Executive VP of Finance & Secretary Conference Call Participants Jim Byers - PondelWilkinson Inc. Christian Schwab - Craig-Hallum Capital Group LLC, Research Division Mark Shooter - William Blair & Company L.L.C., Research Division Bradford Ferguson - Halter Ferguson Financial, Inc. Larry Chlebina - Chlebina Capital Management, LLC Presentation Operator Greetings.
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Aehr Test Systems, Inc.'s latest follow-on orders from its leading AI hyperscaler customer for Sonoma systems represent a significant validation to its technology. AEHR appears to be a key pillar to its hyperscaler customer's long-term plans due to the large-scale deployment of its Sonoma systems. AEHR's consumable BIM sales are likely to grow significantly as the hyperscaler customer intends to ramp production of their own AI processors and introduce new chip designs in CY 2026.